Use of the oral angiotensin I-converting enzyme inhibitor(captopril) in childhood malignant hypertension
- 31 October 1979
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 95 (4) , 641-644
- https://doi.org/10.1016/s0022-3476(79)80787-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Clinical Pharmacology of Antihypertensive Drugs in ChildrenPediatric Clinics of North America, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977
- Angiotensin blockade: Its clinical significanceThe American Journal of Medicine, 1976
- The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.Circulation, 1976
- Angiotensin I converting enzyme.Circulation Research, 1975
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974